Ceredex Value Advisors’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.3M Buy
186,147
+2,743
+1% +$399K 0.77% 40
2026
Q1
$26.5M Buy
+183,404
New +$27.8M 0.83% 31
2018
Q4
Sell
-585,487
Closed -$48.7M 178
2018
Q3
$48.7M Sell
585,487
-624,003
-52% -$51M 0.55% 79
2018
Q2
$94.4M Buy
1,209,490
+281,047
+30% +$21.2M 1.08% 20
2018
Q1
$73.6M Buy
+928,443
New +$77.4M 0.87% 36

Other funds holding PG

Ceredex Value Advisors's PG Position: Q2 2026 in Review

Ceredex Value Advisors increased its Procter & Gamble (PG) stake by 1.5% in Q2 2026, buying an estimated $399K and bringing the position to 186,147 shares worth $27.3M. The position accounts for 0.77% of the portfolio, ranked #40.

Ceredex Value Advisors first reported a position in PG in Q1 2018 and has held it in 5 quarters since. The position peaked at $94.4M in Q2 2018. 4,015 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Ceredex Value Advisors held 186,147 shares of Procter & Gamble worth $27.3M as of Q2 2026.
  • Ceredex Value Advisors bought 2,743 Procter & Gamble shares in Q2 2026, an estimated $399K.
  • Procter & Gamble made up 0.77% of Ceredex Value Advisors's portfolio in Q2 2026, its #40 holding.
  • Ceredex Value Advisors first reported a position in Procter & Gamble in Q1 2018 and has held it in 5 quarters since.
  • Ceredex Value Advisors's Procter & Gamble position peaked at $94.4M in Q2 2018.
  • 4,015 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Ceredex Value Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.